Skip to content
    ALT stock page

    Altimmune, Inc.

    ALT · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 12, 2026

      Altimmune Q2 FY26 — MASH Phase 3 Initiated, Strong AUD Phase 2 Data

      Read the brief

    Browse all US companies on the earnings-call register.